The co-presence of high-risk human papillomaviruses and Epstein-Barr virus is linked with tumor grade and stage in Qatari women with breast cancer

References

• Ferlay J, Colombet M, Soerjomataram I, Mathers C, Parkin DM, Piñeros M, Znaor A, Bray F. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int J Cancer. 2019;144(8):1941–53. doi:10.1002/ijc.31937.
   PubMed Web of Science ®Google Scholar
• Narayan AK, Al-Naemi H, Aly A, Kharita MH, Khera RD, Hajaj M, Rehani MM. Breast cancer detection in Qatar: evaluation of mammography image quality using a standardized assessment tool. Eur J Breast Health. 2020;16(2):124–28. doi:10.5152/ejbh.2020.5115.
   PubMed Web of Science ®Google Scholar
• Donnelly TT, Al Khater A-H, Al Kuwari MG, Al-Bader SB, Al-Meer N, Abdulmalik M, Singh R, Chaudhry S, Fung T. Do socioeconomic factors influence breast cancer screening practices among Arab women in Qatar? BMJ Open. 2015;5(1):e005596–e005596. doi:10.1136/bmjopen-2014-005596.
   PubMed Web of Science ®Google Scholar
• Bener A, Ayub H, Kakil R, Ibrahim W. Patterns of cancer incidence among the population of Qatar: a worldwide comparative study. Asian Pac J Cancer Prev. 2008 Apr 29;9(1):19–24.
   PubMedGoogle Scholar
• Venuti ABG, Rizzo C, Mafera B, Rahimi S, Vigili M. Presence of HPV in head and neck tumours: high prevalence in tonsillar localization. J Exp Clin Cancer Res. 2004;23:561–66.
   PubMed Web of Science ®Google Scholar
• Daling JRMM, Johnson LG, Schwartz SM, Shera KA, Wurscher MA, Carter JJ, Porter PL, Galloway DA, McDougall JK. Human papillomavirus, smoking, and sexual practices in the etiology of anal cancer. Cancer. 2004;101:270–80. doi:10.1002/cncr.20365.
   PubMed Web of Science ®Google Scholar
• Ragin C, Taioli E. Survival of squamous cell carcinoma of the head and neck in relation to human papillomavirus infection: review and meta-analysis. Int J Cancer. 2007;121:1813–20. doi:10.1002/ijc.22851.
   PubMed Web of Science ®Google Scholar
• Shi Y, Peng S-L, Yang L-F, Chen X, Tao Y-G, Cao Y. Co-infection of Epstein-Barr virus and human papillomavirus in human tumorigenesis. Chin J Cancer. 2016;35:16–16. doi:10.1186/s40880-016-0079-1.
   PubMedGoogle Scholar
• Smith JS, Lindsay L, Hoots B, Keys J, Franceschi S, Winer R, Clifford GM. Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: A meta-analysis update. Int J Cancer. 2007;121(3):621–32. doi:10.1002/ijc.22527.
   PubMed Web of Science ®Google Scholar
• Syrjänen KJ. HPV infections and oesophageal cancer. J Clin Pathol. 2002;55(10):721–28. doi:10.1136/jcp.55.10.721.
   PubMed Web of Science ®Google Scholar
• Akil N, Yasmeen A, Kassab A, Ghabreau L, Darnel AD, Al Moustafa AE. High-risk human papillomavirus infections in breast cancer in Syrian women and their association with Id-1 expression: a tissue microarray study. Br J Cancer. 2008;99(3):404–07. doi:10.1038/sj.bjc.6604503.
   PubMed Web of Science ®Google Scholar
• Delgado-García S, Martínez-Escoriza JC, Alba A, Martín-Bayón T-A, Ballester-Galiana H, Peiró G, Caballero P, Ponce-Lorenzo J. Presence of human papillomavirus DNA in breast cancer: a Spanish case-control study. BMC Cancer. 2017;17(1):320. doi:10.1186/s12885-017-3308-3.
   PubMedGoogle Scholar
• Graflund MSB, Sigurdardóttir S, Karlsson M. HPV-DNA, vascular space invasion, and their impact on the clinical outcome in early-stage cervical carcinomas. Int J Gynecol Cancer. 2004;14:896–902. doi:10.1111/j.1048-891X.2004.014527.x.
   PubMed Web of Science ®Google Scholar
• Umudum H, Rezanko T, Dag F, Dogruluk T. Human papillomavirus genome detection by in situ hybridization in fine-needle aspirates of metastatic lesions from head and neck squamous cell carcinomas. Cancer. 2005;105:171–77. doi:10.1002/cncr.21027.
   PubMed Web of Science ®Google Scholar
• Zuna R, Allen RA, Moore WE, Mattu R, Dunn ST. Comparison of human papillomavirus genotypes in high-grade squamous intraepithelial lesions and invasive cervical carcinoma: evidence for differences in biologic potential of precursor lesions. Mod Pathol. 2004;17:1314–22. doi:10.1038/modpathol.3800223.
   PubMed Web of Science ®Google Scholar
• Salman NA, Davies G, Majidy F, Shakir F, Akinrinade H, Perumal D, Ashrafi GH. Association of high risk human papillomavirus and breast cancer: a UK based study. Sci Rep. 2017;7(1):43591. doi:10.1038/srep43591.
   PubMedGoogle Scholar
• Yasmeen A, Bismar TA, Kandouz M, Foulkes WD, Desprez P-Y, Al Moustafa A-E. E6/E7 of HPV type 16 promotes cell invasion and metastasis of human breast cancer cells. Cell Cycle. 2007;6(16):2038–42. doi:10.4161/cc.6.16.4555.
   PubMed Web of Science ®Google Scholar
• Cyprian FS, Al-Farsi HF, Vranic S, Akhtar S, Al Moustafa A-E. Epstein-barr virus and human papillomaviruses interactions and their roles in the initiation of epithelial-mesenchymal transition and cancer progression. Front Oncol. 2018;8:111–111. doi:10.3389/fonc.2018.00111.
   PubMed Web of Science ®Google Scholar
• Shimakage M, Horii K, Tempaku A, Kakudo K, Shirasaka T, Sasagawa T. Association of Epstein-Barr virus with oral cancers. Hum Pathol. 2002;33(6):608–14. doi:10.1053/hupa.2002.129786.
   PubMed Web of Science ®Google Scholar
• Horiuchi K, Mishima K, Ichijima K, Sugimura M, Ishida T, Kirita T. Epstein-Barr virus in the proliferative diseases of squamous epithelium in the oral cavity. Oral Sur Oral Med Oral Pathol Oral Radiol Endodontol. 1995;79(1):57–63. doi:10.1016/S1079-2104(05)80075-7.
   PubMed Web of Science ®Google Scholar
• Boudreault S, Armero VES, Scott MS, Perreault J-P, Bisaillon M. The Epstein-Barr virus EBNA1 protein modulates the alternative splicing of cellular genes. Virol J. 2019;16(1):29. doi:10.1186/s12985-019-1137-5.
   PubMedGoogle Scholar
• McCloskey R, Menges C, Friedman A, Patel D, McCance DJ. Human papillomavirus type 16 E6/E7 upregulation of nucleophosmin is important for proliferation and inhibition of differentiation. J Virol. 2010;84(10):5131–39. doi:10.1128/jvi.01965-09.
   PubMed Web of Science ®Google Scholar
• Al Moustafa A, Foulkes WD, Benlimame N, Wong A, Yen L, Bergeron J, Batist G, Alpert L, Alaoui-Jamali MA. E6/E7 proteins of HPV type 16 and ErbB-2 cooperate to induce neoplastic transformation of primary normal oral epithelial cells. Oncogene. 2004;23:350–58. doi:10.1038/sj.onc.1207148.
   PubMed Web of Science ®Google Scholar
• Al Moustafa A, Kassab A, Darnel A, Yasmeen A. High-risk HPV/ErbB-2 interaction on E-cadherin/catenin regulation in human carcinogenesis. Curr Pharm Des. 2008;14:2159–72. doi:10.2174/138161208785740216.
   PubMed Web of Science ®Google Scholar
• Al Moustafa A-E. E5 and E6/E7 of high-risk HPVs cooperate to enhance cancer progression through EMT initiation. Cell Adh Migr. 2015;9(5):392–93. doi:10.1080/19336918.2015.1042197.
   PubMed Web of Science ®Google Scholar
• Al Moustafa A-E, Al-Antary N, Aboulkassim T, Akil N, Batist G, Yasmeen A. Co-prevalence of Epstein-Barr virus and high-risk human papillomaviruses in Syrian women with breast cancer. Hum Vaccin Immunother. 2016;12(7):1936–39. doi:10.1080/21645515.2016.1139255.
   PubMed Web of Science ®Google Scholar
• Al Moustafa A-E, Chen D, Ghabreau L, Akil N. Association between human papillomavirus and Epstein-Barr virus infections in human oral carcinogenesis. Med Hypotheses. 2009;73(2):184–86. doi:10.1016/j.mehy.2009.02.025.
   PubMed Web of Science ®Google Scholar
• Al Moustafa A-E, Cyprian FS, Al-Antary N, Yasmeen A. High-risk human papillomaviruses and epstein-barr virus presence and crosstalk in human oral carcinogenesis. In: Al Moustafa A-E, editor. Development of oral cancer: risk factors and prevention strategies. Cham, Switzerland: Springer International Publishing; 2017. p. 83–94.
   Google Scholar
• Al-Thawadi H, Ghabreau L, Aboulkassim T, Yasmeen A, Vranic S, Batist G, Al Moustafa A-E. Co-incidence of epstein-barr virus and high-risk human papillomaviruses in cervical cancer of syrian women. Front Oncol. 2018;8:250–250. doi:10.3389/fonc.2018.00250.
   PubMed Web of Science ®Google Scholar
• Al Moustafa A-E, Al-Awadhi R, Missaoui N, Adam I, Durusoy R, Ghabreau L, Akil N, Ahmed HG, Yasmeen A, Alsbeih G, et al. Human papillomaviruses-related cancers. Presence and prevention strategies in the Middle East and North African regions. Hum Vaccin Immunother. 2014;10(7):1812–21. doi:10.4161/hv.28742.
   PubMed Web of Science ®Google Scholar
• Al Moustafa A-E. Role of high-risk human papillomaviruses in breast carcinogenesis. In: Gupta S, editor. Breast carcinogenesis; Oncoviruses and their inhibitors. Boca Raton, Florida: CRC: Taylor and Francis Group; 2014. p. 245–62.
   Google Scholar
• de Cremoux P, Thioux M, Lebigot I, Sigal-Zafrani B, Salmon R, Sastre-Garau X. No evidence of human papillomavirus DNA sequences in invasive breast carcinoma. Breast Cancer Res Treat. 2008;109(1):55–58. doi:10.1007/s10549-007-9626-4.
   PubMed Web of Science ®Google Scholar
• Hedau S, Kumar U, Hussain S, Shukla S, Pande S, Jain N, Tyagi A, Deshpande T, Bhat D, Mir MM, et al. Breast cancer and human papillomavirus infection: no evidence of HPV etiology of breast cancer in Indian women. BMC Cancer. 2011;11(1):27. doi:10.1186/1471-2407-11-27.
   PubMedGoogle Scholar
• Brumbaugh J, Ferris RL, Hu S. HPV and EBV in head and neck cancer. In: Bernier J, editor. Head and neck cancer: multimodality management. Cham, Switzerland: Springer International Publishing; 2016. p. 163–79.
   Google Scholar
• Malki MI, Gupta I, Fernandes Q, Aboulkassim T, Yasmeen A, Vranic S, Al Moustafa A-E, Al-Thawadi HA. Co-presence of Epstein-Barr virus and high-risk human papillomaviruses in Syrian colorectal cancer samples. Hum Vaccin Immunother. 2020:1–5. doi:10.1080/21645515.2020.1726680.
   PubMed Web of Science ®Google Scholar
• Al-Thawadi H, Gupta I, Jabeen A, Skenderi F, Aboulkassim T, Yasmeen A, Malki MI, Batist G, Vranic S, Al Moustafa A-E. Co-presence of human papillomaviruses and Epstein–Barr virus is linked with advanced tumor stage: a tissue microarray study in head and neck cancer patients. Cancer Cell Int. 2020;20:1–13. doi:10.1186/s12935-020-01348-y.
   Web of Science ®Google Scholar
• Elston CW, Ellis IO. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology. 1991;19(5):403–10. doi:10.1111/j.1365-2559.1991.tb00229.x.
   PubMed Web of Science ®Google Scholar
• Allison KH, Hammond MEH, Dowsett M, McKernin SE, Carey LA, Fitzgibbons PL, Hayes DF, Lakhani SR, Chavez-MacGregor M, Perlmutter J, et al. Estrogen and progesterone receptor testing in breast cancer: ASCO/CAP guideline update. J Clin Oncol. 2020;38(12):1346–66. doi:10.1200/jco.19.02309.
   PubMed Web of Science ®Google Scholar
• Wolff AC, Hammond MEH, Allison KH, Harvey BE, Mangu PB, Bartlett JMS, Bilous M, Ellis IO, Fitzgibbons P, Hanna W, et al. Human epidermal growth factor receptor 2 testing in breast cancer: American society of clinical oncology/college of American pathologists clinical practice guideline focused update. Arch Pathol Lab Med. 2018;142(11):1364–82. doi:10.5858/arpa.2018-0902-SA.
   PubMed Web of Science ®Google Scholar
• Gupta I, Nasrallah GK, Sharma A, Jabeen A, Smatti MK, Al-Thawadi HA, Sultan AA, Alkhalaf M, Vranic S, Moustafa AA. Co-prevalence of human papillomaviruses (HPV) and Epstein-Barr virus (EBV) in healthy blood donors from diverse nationalities in Qatar. Cancer Cell Int. 2020;20:107–107. doi:10.1186/s12935-020-01190-2.
   PubMed Web of Science ®Google Scholar
• Gupta I, Al Farsi H, Jabeen A, Skenderi F, Al-Thawadi H, AlAhmad YM, Abdelhafez I, Al Moustafa A-E, Vranic S. High-risk human papillomaviruses and Epstein–Barr virus in colorectal cancer and their association with clinicopathological status. Pathogens. 2020;9(6):452. doi:10.3390/pathogens9060452.
   PubMed Web of Science ®Google Scholar
• Heng B, Glenn WK, Ye Y, Tran B, Delprado W, Lutze-Mann L, Whitaker NJ, Lawson JS. Human papilloma virus is associated with breast cancer. Br J Cancer. 2009;101(8):1345–50. doi:10.1038/sj.bjc.6605282.
   PubMed Web of Science ®Google Scholar
• Xiao C-Y, Fu -B-B, Li Z-Y, Mushtaq G, Kamal MA, Li J-H, Tang G-C, Xiao -S-S. Observations on the expression of human papillomavirus major capsid protein in HeLa cells. Cancer Cell Int. 2015;15:53–53. doi:10.1186/s12935-015-0206-0.
   PubMed Web of Science ®Google Scholar
• Zur Hausen H. Papillomaviruses in the causation of human cancers — a brief historical account. Virology. 2009;384(2):260–65. doi:10.1016/j.virol.2008.11.046.
   PubMed Web of Science ®Google Scholar
• Khodabandehlou N, Mostafaei S, Etemadi A, Ghasemi A, Payandeh M, Hadifar S, Norooznezhad AH, Kazemnejad A, Moghoofei M. Human papilloma virus and breast cancer: the role of inflammation and viral expressed proteins. BMC Cancer. 2019;19(1):61. doi:10.1186/s12885-019-5286-0.
   PubMedGoogle Scholar
• Herrera-Goepfert R, Vela-Chávez T, Carrillo-García A, Lizano-Soberón M, Amador-Molina A, Oñate-Ocaña LF, Hallmann RSR. High-risk human papillomavirus (HPV) DNA sequences in metaplastic breast carcinomas of Mexican women. BMC Cancer. 2013;13(1):445. doi:10.1186/1471-2407-13-445.
   PubMedGoogle Scholar
• Khan NA, Castillo A, Koriyama C, Kijima Y, Umekita Y, Ohi Y, Higashi M, Sagara Y, Yoshinaka H, Tsuji T, et al. Human papillomavirus detected in female breast carcinomas in Japan. Br J Cancer. 2008;99(3):408–14. doi:10.1038/sj.bjc.6604502.
   PubMed Web of Science ®Google Scholar
• Fernandes A, Bianchi G, Feltri AP, Pérez M, Correnti M. Presence of human papillomavirus in breast cancer and its association with prognostic factors. Ecancermedicalscience. 2015;9:548. doi:10.3332/ecancer.2015.548.
   PubMed Web of Science ®Google Scholar
• Gumus M, Yumuk PF, Salepci T, Aliustaoglu M, Dane F, Ekenel M, Basaran G, Kaya H, Barisik N, Turhal NS, et al. HPV DNA frequency and subset analysis in human breast cancer patients’ normal and tumoral tissue samples. J Exp Clin Cancer Res. 2006 Jan 22;25(4):515–21.
   PubMed Web of Science ®Google Scholar
• Ali SH, Al-Alwan NA, Al-Alwany SH. Detection and genotyping of human papillomavirus in breast cancer tissues from Iraqi patients. East Mediterr Health J. 2014 Jun 25;20(6):372–77. doi:10.26719/2014.20.6.372.
   PubMed Web of Science ®Google Scholar
• Sigaroodi A, Nadji SA, Naghshvar F, Nategh R, Emami H, Velayati AA. Human papillomavirus is associated with breast cancer in the north part of Iran. Sci World J. 2012;2012:837191–837191. doi:10.1100/2012/837191.
   Google Scholar
• Ahangar-Oskouee M, Shahmahmoodi S, Jalilvand S, Mahmoodi M, Ziaee AA, Esmaeili H-A, Keshtvarz M, Pishraft-Sabet L, Yousefi M, Mollaei-Kandelous Y, et al. No detection of ‘high-risk’ human papillomaviruses in a group of Iranian women with breast cancer. Asian Pac J Cancer Prev. 2014;15(9):4061–65. doi:10.7314/apjcp.2014.15.9.4061.
   PubMedGoogle Scholar
• Manzouri L, Salehi R, Shariatpanahi S, Rezaie P. Prevalence of human papilloma virus among women with breast cancer since 2005–2009 in Isfahan. Adv Biomed Res. 2014;3:75. doi:10.4103/2277-9175.125873.
   PubMedGoogle Scholar
• Elmi A, Bansal D, Al-Thani A, Al-Ansari A, Mohamed N, Sultan A. Molecular epidemiology of human papillomavirus among Arab women in Qatar. Qatar Foundation Annual Research Forum Proceedings. 2012;2012(1). doi:10.5339/qfarf.2012.BMP6.
   Google Scholar
• Bansal D, Elmi AA, Skariah S, Haddad P, Abu-Raddad LJ, Al Hamadi AH, Mohamed-Nady N, Affifi NM, Ghedira R, Hassen E, et al. Molecular epidemiology and genotype distribution of human papillomavirus (HPV) among Arab women in the state of Qatar. J Transl Med. 2014;12(1):300. doi:10.1186/s12967-014-0300-4.
   PubMedGoogle Scholar
• Moosa K, Alsayyad AS, Quint W, Gopala K, DeAntonio R. An epidemiological study assessing the prevalence of human papillomavirus types in women in the Kingdom of Bahrain. BMC Cancer. 2014;14:905–905. doi:10.1186/1471-2407-14-905.
   PubMed Web of Science ®Google Scholar
• AlObaid A, Al-Badawi IA, Al-Kadri H, Gopala K, Kandeil W, Quint W, Al-Aker M, DeAntonio R. Human papillomavirus prevalence and type distribution among women attending routine gynecological examinations in Saudi Arabia. BMC Infect Dis. 2014;14(1):643. doi:10.1186/s12879-014-0643-8.
   PubMedGoogle Scholar
• Al-Awadhi R, Chehadeh W, Jaragh M, Al-Shaheen A, Sharma P, Kapila K. Distribution of human papillomavirus among women with abnormal cervical cytology in Kuwait. Diagn Cytopathol. 2013;41(2):107–14. doi:10.1002/dc.21778.
   PubMed Web of Science ®Google Scholar
• Yu Y, Morimoto T, Sasa M, Okazaki K, Harada Y, Fujiwara T, Irie Y, Takahashi E-I, Tanigami A, Izumi K, et al. Human papillomavirus type 33 DNA in breast cancer in Chinese. Breast Cancer. 2000;7(1):33–36. doi:10.1007/BF02967185.
   PubMedGoogle Scholar
• Lawson JS, Glenn WK, Salyakina D, Delprado W, Clay R, Antonsson A, Heng B, Miyauchi S, Tran DD, Ngan CC, et al. Human papilloma viruses and breast cancer. Front Oncol. 2015;5:277–277. doi:10.3389/fonc.2015.00277.
   PubMed Web of Science ®Google Scholar
• Wang T, Chang P, Wang L, Yao Q, Guo W, Chen J, Yan T, Cao C. The role of human papillomavirus infection in breast cancer. Med Oncol. 2012;29(1):48–55. doi:10.1007/s12032-010-9812-9.
   PubMed Web of Science ®Google Scholar
• De Carolis S, Storci G, Ceccarelli C, Savini C, Gallucci L, Sansone P, Santini D, Seracchioli R, Taffurelli M, Fabbri F, et al. HPV DNA associates with breast cancer malignancy and it is transferred to breast cancer stromal cells by extracellular vesicles. Front Oncol. 2019;9(860). doi:10.3389/fonc.2019.00860
   Google Scholar
• Corbex M, Bouzbid S, Traverse-Glehen A, Aouras H, McKay-Chopin S, Carreira C, Lankar A, Tommasino M, Gheit T. Prevalence of papillomaviruses, polyomaviruses, and herpesviruses in triple-negative and inflammatory breast tumors from algeria compared with other types of breast cancer tumors. Plos One. 2014;9(12):e114559. doi:10.1371/journal.pone.0114559.
   PubMed Web of Science ®Google Scholar
• Piana AF, Sotgiu G, Muroni MR, Cossu-Rocca P, Castiglia P, De Miglio MR. HPV infection and triple-negative breast cancers: an Italian case-control study. Virol J. 2014;11(1):190. doi:10.1186/s12985-014-0190-3.
   PubMedGoogle Scholar
• Glenn WK, Heng B, Delprado W, Iacopetta B, Whitaker NJ, Lawson JS. Epstein-Barr virus, human papillomavirus and mouse mammary tumour virus as multiple viruses in breast cancer. PloS One. 2012;7(11):e48788–e48788. doi:10.1371/journal.pone.0048788.
   PubMed Web of Science ®Google Scholar
• Joshi D, Quadri M, Gangane N, Joshi R, Gangane N. Association of Epstein Barr virus infection (EBV) with breast cancer in rural Indian women. PloS One. 2009;4(12):e8180–e8180. doi:10.1371/journal.pone.0008180.
   PubMed Web of Science ®Google Scholar
• Lorenzetti MA, De Matteo E, Gass H, Martinez Vazquez P, Lara J, Gonzalez P, Preciado MV, Chabay PA. Characterization of Epstein Barr virus latency pattern in Argentine breast carcinoma. PloS One. 2010;5(10):e13603–e13603. doi:10.1371/journal.pone.0013603.
   PubMed Web of Science ®Google Scholar
• Fawzy S, Sallam M, Awad NM. Detection of Epstein-Barr virus in breast carcinoma in Egyptian women. Clin Biochem. 2008;41(7–8):486–92. doi:10.1016/j.clinbiochem.2007.12.017.
   PubMed Web of Science ®Google Scholar
• Xue SA, Lampert IA, Haldane JS, Bridger JE, Griffin BE. Epstein-Barr virus gene expression in human breast cancer: protagonist or passenger? Br J Cancer. 2003;89(1):113–19. doi:10.1038/sj.bjc.6601027.
   PubMed Web of Science ®Google Scholar
• Kalkan A, Ozdarendeli A, Bulut Y, Yekeler H, Cobanoglu B, Doymaz MZ. Investigation of Epstein-Barr virus DNA in formalin-fixed and paraffin- embedded breast cancer tissues. Med Princ Pract. 2005;14(4):268–71. doi:10.1159/000085748.
   PubMed Web of Science ®Google Scholar
• Aboulkassim T, Yasmeen A, Akil N, Batist G, Al Moustafa A-E. Incidence of Epstein-Barr virus in Syrian women with breast cancer: A tissue microarray study. Hum Vaccin Immunother. 2015;11(4):951–55. doi:10.1080/21645515.2015.1009342.
   PubMed Web of Science ®Google Scholar
• Zekri A-RN, Bahnassy AA, Mohamed WS, El-Kassem FA, El-Khalidi SJ, Hafez MM, Hassan ZK. Epstein-Barr virus and breast cancer: epidemiological and molecular study on Egyptian and Iraqi women. J Egypt Natl Cancer Inst. 2012;24(3):123–31. doi:10.1016/j.jnci.2012.06.001.
   PubMedGoogle Scholar
• Hachana M, Amara K, Ziadi S, Romdhane E, Gacem RB, Trimeche M. Investigation of Epstein-Barr virus in breast carcinomas in Tunisia. Pathol Res Pract. 2011;207(11):695–700. doi:10.1016/j.prp.2011.09.007.
   PubMed Web of Science ®Google Scholar
• Sharifpour C, Makvandi M, Samarbafzadeh A, Talaei-Zadeh A, Ranjbari N, Nisi N, Azaran A, Jalilian S, Varnaseri M, Pirmoradi R, et al. Frequency of Epstein–Barr virus DNA in formalin-fixed paraffin-embedded tissue of patients with ductal breast carcinoma. Asian Pac J Cancer Prev. 2019;20(3):687–92. doi:10.31557/apjcp.2019.20.3.687.
   PubMedGoogle Scholar
• Farahmand M, Monavari SH, Shoja Z, Ghaffari H, Tavakoli M, Tavakoli A. Epstein-Barr virus and risk of breast cancer: a systematic review and meta-analysis. Future Oncol. 2019;15(24):2873–85. doi:10.2217/fon-2019-0232.
   PubMed Web of Science ®Google Scholar
• Lawson JS, Glenn WK. Multiple oncogenic viruses are present in human breast tissues before development of virus associated breast cancer. Infect Agent Cancer. 2017;12(1):55. doi:10.1186/s13027-017-0165-2.
   PubMedGoogle Scholar
• Naushad W, Surriya O, Sadia H. Prevalence of EBV, HPV and MMTV in Pakistani breast cancer patients: A possible etiological role of viruses in breast cancer. Infec Genet Evol. 2017;54:230–37. doi:10.1016/j.meegid.2017.07.010.
   PubMed Web of Science ®Google Scholar
• Fina F, Romain S, Ouafik L, Palmari J, Ayed FB, Benharkat S, Bonnier P, Spyratos F, Foekens JA, Rose C, et al. Frequency and genome load of Epstein-Barr virus in 509 breast cancers from different geographical areas. Br J Cancer. 2001;84(6):783–90. doi:10.1054/bjoc.2000.1672.
   PubMed Web of Science ®Google Scholar
• Horakova D, Bouchalova K, Cwiertka K, Stepanek L, Vlckova J, Kollarova H. Risks and protective factors for triple negative breast cancer with a focus on micronutrients and infections. Biomedical Papers. 2018;162(2):83–89. doi:10.5507/bp.2018.014.
   PubMed Web of Science ®Google Scholar
• Corbex M, Bouzbid S, Boffetta P. Features of breast cancer in developing countries, examples from North-Africa. Eur J Cancer. 2014;50(10):1808–18. doi:10.1016/j.ejca.2014.03.016.
   PubMed Web of Science ®Google Scholar
• Lawson JS, Salmons B, Glenn WK. Oncogenic viruses and breast cancer: mouse mammary tumor virus (MMTV), bovine leukemia virus (BLV), human papilloma virus (HPV), and Epstein-Barr virus (EBV). Front Oncol. 2018;8:1–1. doi:10.3389/fonc.2018.00001.
   PubMed Web of Science ®Google Scholar
• Aguayo F, Khan N, Koriyama C, González C, Ampuero S, Padilla O, Solís L, Eizuru Y, Corvalán A, Akiba S, et al. Human papillomavirus and Epstein-Barr virus infections in breast cancer from chile. Infect Agent Cancer. 2011;6(1):7–7. doi:10.1186/1750-9378-6-7.
   PubMedGoogle Scholar
• Gupta I, Al Farsi H, Jabeen A, Skendri F, Al-Thawadi H, AlAhmad YM, Al Moustafa AE, Vranic S. High-risk human papillomaviruses and Epstein-Barr virus in colorectal cancer and their association with clinicopathological status. Pathogens. 2020;9: (In Press). doi:10.3390/pathogens9060452.
   Web of Science ®Google Scholar
• Gupta I, Jabeen A, Skenderi F, Malki MI, Al-Thawadi H, Al Moustafa AE, Vranic S. High-risk human papillomaviruses (HPV) and Epstein - Barr virus (EBV) are commonly present in rectal cancer. Mod Pathol. 2020;33:676.
   PubMed Web of Science ®Google Scholar
• Gupta I, Ghabreau L, Al-Thawadi H, Yasmeen A, Vranic S, Al Moustafa AE, Malki MI. Co-incidence of human papillomaviruses and Epstein-Barr virus is associated with high to intermediate tumor grade in human head and neck cancer in Syria. Front Oncol. 2020. doi:10.3389/fonc.2020.01016.
   Web of Science ®Google Scholar